nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00965	0.0622	CbGeAlD
Aclidinium—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00954	0.0614	CbGeAlD
Aclidinium—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.0093	0.0598	CbGeAlD
Aclidinium—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00869	0.0559	CbGeAlD
Aclidinium—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00807	0.0519	CbGeAlD
Aclidinium—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00777	0.05	CbGeAlD
Aclidinium—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00755	0.0486	CbGeAlD
Aclidinium—CHRM4—brain—attention deficit hyperactivity disorder	0.00738	0.0475	CbGeAlD
Aclidinium—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00734	0.0473	CbGeAlD
Aclidinium—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00727	0.0468	CbGeAlD
Aclidinium—BCHE—forebrain—attention deficit hyperactivity disorder	0.00634	0.0408	CbGeAlD
Aclidinium—CHRM5—brain—attention deficit hyperactivity disorder	0.00577	0.0371	CbGeAlD
Aclidinium—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00536	0.0345	CbGeAlD
Aclidinium—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00518	0.0334	CbGeAlD
Aclidinium—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00499	0.0321	CbGeAlD
Aclidinium—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00471	0.0304	CbGeAlD
Aclidinium—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00454	0.0292	CbGeAlD
Aclidinium—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00422	0.0272	CbGeAlD
Aclidinium—BCHE—midbrain—attention deficit hyperactivity disorder	0.00419	0.027	CbGeAlD
Aclidinium—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00406	0.0262	CbGeAlD
Aclidinium—CHRM2—brain—attention deficit hyperactivity disorder	0.00396	0.0255	CbGeAlD
Aclidinium—CHRM1—brain—attention deficit hyperactivity disorder	0.0036	0.0232	CbGeAlD
Aclidinium—BCHE—nervous system—attention deficit hyperactivity disorder	0.00344	0.0222	CbGeAlD
Aclidinium—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00332	0.0213	CbGeAlD
Aclidinium—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00324	0.0209	CbGeAlD
Aclidinium—CHRM3—brain—attention deficit hyperactivity disorder	0.00323	0.0208	CbGeAlD
Aclidinium—BCHE—brain—attention deficit hyperactivity disorder	0.00263	0.0169	CbGeAlD
Aclidinium—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000732	0.000867	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000723	0.000856	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000723	0.000856	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000718	0.00085	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000716	0.000848	CbGpPWpGaD
Aclidinium—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000714	0.000846	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000714	0.000846	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000709	0.000839	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000707	0.000837	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000703	0.000832	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0007	0.000829	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000695	0.000823	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000694	0.000821	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000692	0.00082	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00068	0.000806	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000678	0.000803	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000672	0.000795	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000669	0.000792	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000667	0.000789	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000666	0.000788	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000661	0.000782	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00066	0.000782	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000658	0.00078	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000658	0.000779	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000656	0.000777	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000652	0.000772	CbGpPWpGaD
Aclidinium—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000651	0.00077	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00065	0.000769	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00065	0.000769	CbGpPWpGaD
Aclidinium—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000649	0.000768	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000639	0.000757	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000622	0.000737	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000615	0.000728	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000613	0.000726	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000612	0.000725	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000607	0.000719	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000582	0.000689	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00058	0.000687	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000575	0.000681	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000574	0.000679	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000568	0.000673	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000552	0.000653	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000548	0.000649	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000546	0.000647	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000541	0.00064	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000537	0.000635	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000535	0.000633	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000535	0.000633	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000533	0.000631	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00053	0.000627	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000528	0.000626	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000528	0.000625	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000518	0.000613	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000516	0.000611	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000511	0.000606	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000509	0.000603	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000508	0.000601	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000507	0.000601	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000503	0.000596	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000503	0.000595	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000503	0.000595	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000501	0.000594	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000501	0.000594	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000501	0.000593	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000498	0.000589	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000497	0.000588	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000497	0.000588	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000496	0.000587	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000491	0.000581	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000487	0.000577	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000487	0.000576	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000486	0.000575	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000486	0.000575	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000482	0.000571	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000481	0.00057	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00048	0.000568	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000469	0.000555	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000467	0.000553	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000466	0.000552	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000463	0.000548	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000462	0.000547	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000456	0.000539	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000448	0.000531	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000438	0.000519	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000438	0.000519	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000437	0.000517	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000436	0.000516	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000434	0.000514	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000433	0.000512	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000431	0.00051	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00043	0.000509	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000429	0.000508	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000427	0.000506	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000427	0.000505	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000425	0.000504	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000422	0.000499	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000419	0.000497	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000419	0.000496	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000417	0.000494	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000416	0.000492	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000409	0.000484	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000409	0.000484	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000407	0.000482	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000404	0.000478	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000401	0.000475	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000394	0.000467	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000393	0.000466	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000393	0.000465	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00039	0.000462	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000388	0.000459	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000383	0.000453	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000378	0.000447	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000376	0.000445	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000372	0.00044	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000371	0.000439	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000371	0.000439	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000367	0.000435	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000367	0.000434	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000357	0.000422	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00035	0.000415	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000342	0.000405	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000342	0.000404	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000341	0.000404	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000338	0.0004	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000338	0.0004	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000337	0.000399	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000334	0.000395	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000328	0.000389	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000327	0.000387	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000325	0.000385	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000325	0.000385	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000324	0.000384	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000324	0.000384	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000321	0.00038	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000315	0.000372	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000315	0.000372	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000309	0.000366	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000302	0.000358	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000301	0.000357	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000298	0.000353	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000296	0.00035	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000295	0.00035	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000294	0.000349	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000294	0.000348	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000293	0.000347	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000293	0.000347	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000292	0.000346	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000292	0.000345	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00029	0.000343	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000289	0.000342	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000288	0.000341	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000288	0.000341	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000288	0.000341	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000287	0.00034	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000287	0.00034	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000284	0.000337	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000284	0.000337	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000284	0.000336	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000283	0.000336	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000283	0.000335	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000282	0.000334	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000281	0.000333	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000281	0.000332	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000279	0.00033	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000275	0.000326	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000275	0.000325	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000274	0.000324	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000271	0.000321	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000266	0.000315	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000265	0.000314	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000265	0.000313	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000264	0.000312	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000263	0.000312	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000262	0.000311	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000261	0.000309	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000261	0.000309	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000261	0.000308	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000259	0.000306	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000258	0.000306	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000305	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000257	0.000305	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000255	0.000302	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000251	0.000298	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00025	0.000296	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000248	0.000293	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000242	0.000286	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000242	0.000286	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000241	0.000285	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00024	0.000285	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00024	0.000284	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000239	0.000283	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000239	0.000283	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000238	0.000282	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000237	0.000281	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000233	0.000276	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00023	0.000273	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000229	0.000271	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000226	0.000268	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000223	0.000264	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000221	0.000262	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000219	0.00026	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000217	0.000256	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000211	0.000249	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000202	0.000239	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.0002	0.000236	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000199	0.000236	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000197	0.000233	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000193	0.000229	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000191	0.000226	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000189	0.000224	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000185	0.00022	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000185	0.000219	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000184	0.000218	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000183	0.000217	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000183	0.000217	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000174	0.000207	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000174	0.000206	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000172	0.000204	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000168	0.000199	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000168	0.000199	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000166	0.000197	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000162	0.000192	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000162	0.000191	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00016	0.00019	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000157	0.000186	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000157	0.000185	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000155	0.000184	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.000183	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.000182	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000152	0.000181	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.00018	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000152	0.00018	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000151	0.000178	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000148	0.000175	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000147	0.000173	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000145	0.000172	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000142	0.000168	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000142	0.000168	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000141	0.000167	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00014	0.000166	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.95e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.92e-05	0.000117	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.82e-05	0.000116	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	8.17e-05	9.67e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.82e-05	9.25e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.49e-05	8.86e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.28e-05	7.44e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.27e-05	6.24e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.25e-05	6.22e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.2e-05	6.16e-05	CbGpPWpGaD
